Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination

Lignende værker

• European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
  af: Claire L. Shovlin, et al.
  Udgivet: (2018-08-01)
• Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
  af: Buscarini, Elisabetta, et al.
  Udgivet: (2019)
• Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
  af: Shovlin, C. L., et al.
  Udgivet: (2019)
• European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
  af: Eker, Omer F., et al.
  Udgivet: (2020)
• Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature
  af: Dupuis, Olivier, et al.
  Udgivet: (2020)